Jump to content

Beximco Pharma

From Wikipedia, the free encyclopedia
Beximco Pharmaceuticals Ltd
Company typeLimited
DSE: BXPHARMA
LSE: BXP
IndustryPharmaceutical
Founded1980
HeadquartersDhanmondi, Dhaka, Bangladesh
Key people
Iqbal Ahmed (Managing Director)
RevenueIncrease ৳3926.7 crore (US$330 million) (2023)[1]
Increase ৳691.2 crore (US$58 million) (2023)[1]
Decrease ৳461.4 crore (US$39 million) (2023)[1]
Number of employees
4,523 (2019)[2]
WebsiteOfficial Website

Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company.[3] It is a part of Bangladesh Export Import Company Limited (BEXIMCO).[4]

History

[edit]

Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States.[5] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US.[6]

In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment.[7][8][9] Beximco Pharma became the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along with Eskayef Pharmaceuticals.[10][11] Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir.[12]

Factories

[edit]

Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m2) site located in Dhaka, Bangladesh.[13] The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.

Exports

[edit]

In August 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs.

References

[edit]
  1. ^ a b c "Beximco Pharmaceuticals Ltd". WSJ. Retrieved 18 January 2024.
  2. ^ "Beximco Pharma Annual Report 2018-19" (PDF). Retrieved 23 December 2019.
  3. ^ "BD firm plans to export version of Tamiflu". Daily Times. 5 April 2006. Archived from the original on 6 June 2011. Retrieved 8 March 2008.
  4. ^ "Bangladesh forays into US market with Beximco Pharma". bdnews24.com. Retrieved 3 October 2016.
  5. ^ "Beximco Pharma Q3 revenue up". The Pharma Letter. Retrieved 3 October 2016.
  6. ^ "US FDA approves Beximco Pharma's blood pressure drug". Dhaka Tribune. Archived from the original on 30 September 2016. Retrieved 3 October 2016.
  7. ^ "Beximco introduces remdesivir for Covid-19 treatment". The Daily Star. 21 May 2020. Retrieved 24 May 2020.
  8. ^ "Beximco Pharma introduces world's first generic Remdesivir for COVID-19 treatment". The Financial Express. Dhaka. Retrieved 24 May 2020.
  9. ^ Siddiqui, Zeba (5 May 2020). "Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO". Reuters. Retrieved 6 March 2021.
  10. ^ Pilla, Viswanath (December 30, 2021). "Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviral". The Economic Times. Retrieved June 26, 2024.
  11. ^ "Beximco Pharma gets license for oral anti-Covid drug". The Business Standard. January 20, 2022. Retrieved June 26, 2024.
  12. ^ "Merck's COVID-19 pill molnupiravir hits Bangladesh markets". The Financial Express. June 26, 2024. Retrieved June 26, 2024.
  13. ^ "Beximco Pharma's Q3 profits soar 51%". The Daily Star. April 30, 2024. Retrieved June 26, 2024.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Beximco_Pharma&oldid=1256966699"